You just read:

Eisai Presents Data on BACE Inhibitor Elenbecestat (E2609) at 9th Clinical Trials on Alzheimer's Disease (CTAD) Meeting

News provided by

Eisai Inc.

12 Dec, 2016, 08:06 ET